AS021 activity and Satb2 expression decrease within deep layers at postnatal stages. by Kensuke Tashiro (193459)

“…(E–G″′) Immunostaining for Satb2 (red), Ctip2 (blue), and βgal (green) in coronal sections of P2 AS021-lacZ brains reveals a strong decrease of Satb2 staining specifically in deep layers. …”

Fig 2 - by Amberleigh E. Henschen (3257235)

Colony survival is decreased in 2'-O-ribose <i>trm</i> mutants after exposure to oxidative stress-inducing agents. by Lauren Endres (765718)

TPI demalonylation at K56 decreases PPP flux in CDCP1+ CSCs and is indispensable for postchemotherapeutic recurrence. by WenChao Gao (7321640)

(A) Decrease in Soret band absorbance; (B) images and the percentages of metmyoglobin (MetMb), deoxymyoglobin (DeoMb) and oxymyoglobin (OxyMb) in native Mb and Mb-GlcN conjugates over glycation period from 0.5 to 12 days. by Yuliya Hrynets (800300)

“…<p>(A) Decrease in Soret band absorbance; (B) images and the percentages of metmyoglobin (MetMb), deoxymyoglobin (DeoMb) and oxymyoglobin (OxyMb) in native Mb and Mb-GlcN conjugates over glycation period from 0.5 to 12 days.…”

Decreased Fhl1b activity augments induction of pancreatic endocrine cells. by Jin Xu (31283)

MAF1 protein expression is significantly decreased in luminal, HER2-positive, and TNBC breast cancer subtypes. by Stephanie Cabarcas-Petroski (9631636)

Decreased expression levels of the MYO6 protein in <i>ksv</i> mice. by Yuta Seki (4385833)

“…Expression of MYO6 is completely ablated in the hair cells of <i>Myo6</i>^-/- mice (C). Scale bar = 5 μm. D and E. Western blot analysis of homogenates prepared from the inner ears of +/+, +/<i>ksv</i> and <i>ksv/ksv</i> mice at P30 detected with anti-MYO6 (N-ter, D) and MYO6 (C-ter, E) antibodies (<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0183477#pone.0183477.s007" target="_blank">S2 Table</a>). …”

WCESP (2 mg/ml) decreases <i>V</i>. <i>cholerae</i> cell-surface hydrophobicity. by Daniel B. Pederson (604306)

9 mo Pkd2+/- mice have decreased ejection fraction and ventricular remodeling. by Ivana Y. Kuo (707543)

Disruption of FGFR1-Frs2/3 pathway decreases the number of support cells. by Kazuya Ono (513633)

Decreased capillary density and cardiac fibrosis in <i>Nkx2.5-Cre/Foxm1^fl/fl</i> heart. by Craig Bolte (299486)

“…Capillary density was decreased in <i>Nkx2.5-Cre/Foxm1^fl/fl</i> hearts at P11 (A–B, I), while coronary vessel formation was not altered (C–D). …”

Six weeks of voluntary wheel running decreases 5-HT_2C mRNA expression in the medial dorsal striatum. by Benjamin N. Greenwood (295216)

Five-hours-old clots were subjected to scanning electron microscopy. by Jan Víteček (11434774)

Pharmacokinetic analysis of LY5 in mice and normal dogs. by Peter Y. Yu (4281448)

Specific Cyt2 triggering increases CTLA-4 expression and decreases LAT phosphorylation. by Siobhan Ni Choileain (124123)

Interpretation of HD sensitization as a change of inhibitory tone to the HD. by Abolhassan Behrouzvaziri (741985)

SPL treatment decreases diabetes-induced decrement in protein expression of cldn-5 in glomeruli (GL) and cldn-2 and occldn in proximal tubules (PT). by Eduardo Molina-Jijón (4020464)

“…<p>SPL prevents diabetes-induced decrease of cldn-5 protein expression (A and B) in GL, and mRNA (F) and protein expression of cldn-2 (A and C), and protein expression of occldn (A and D) in PT (<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0177362#pone.0177362.s002" target="_blank">S2 Fig</a>). …”

Cortical distribution of neurons born at E11.5, E13.5, E15.5, or E17.5 in P0 mice. by Qingfa Chen (739620)

“…In <i>Nestin;Epha4</i>^<i>fx/fx</i> mice, a larger number of CTIP2+ cells was co-labeled with BrdU at E11.5 but fewer were co-labeled at E13.5 compared to controls (C), whereas in <i>GFAP;Epha4</i>^<i>fx/fx</i> mice, the number of co-labeled cells was similar to that of controls at both E11.5 and E13.5 (D). …”

Discovery of a Colon-Targeted Azo Prodrug of Tofacitinib through the Establishment of Colon-Specific Delivery Systems Constructed by 5‑ASA–PABA–MAC and 5‑ASA–PABA–Diamine for the T... by Jiaxing Zhao (3965057)

“…To mitigate the systemic adverse effects of tofacitinib, 5-ASA–PABA–MAC and 5-ASA–PABA–diamine colon-specific delivery systems were constructed, and tofacitinib azo prodrugs <b>9</b> and <b>20a–20g</b> were synthesized accordingly. …”